J&J, Bristol Myers lose challenges to US drug price negotiation program - Reuters

Reuters | April 29, 2024, 5:58 p.m. | Original
J&J, Bristol Myers lose challenges to US drug price negotiation program Reuters
Morning Bid: Dollar recoils at 160 yen, Tesla's China joy - Reuters F5 issues downbeat forecast on weak demand for IT-related services - Reuters